Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures

Sponsor
Uppsala University (Other)
Overall Status
Completed
CT.gov ID
NCT02535624
Collaborator
Shandong Provincial Hospital (Other)
56
1
2
120
0.5

Study Details

Study Description

Brief Summary

This study is designed to answer whether minimal invasive vessel clotting (angioembolization) or open surgery (retroperitoneal packing) is more effective for pelvic fractures with massive bleeding. Patients admitted at daytime (7am-5pm) are treated with angioembolization while patients admitted at nighttime (5pm to 7am) are treated with open surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: PACKING
  • Procedure: ANGIO
N/A

Detailed Description

In patients with pelvic fracture uncontrollable bleeding is the major cause of death within the first 24h after injury. Early hemorrhage control is therefore vital for successful treatment. Nowadays, recommended techniques for hemorrhage control in pelvic fractures are retroperitoneal pelvic packing and angioembolization, dependent upon the available technical staff and resources and the condition of the patient.

Retroperitoneal pelvic packing, on the one hand, is a relatively simple method in controlling pelvic hemorrhage even with limited resources. Since 89% of pelvic fracture hemorrhage originates from venous bleeding, fracture stabilization and compressive hemostasis by packing is a reasonable approach. Angioembolization, on the other hand, has great high effectiveness with regard to bleeding control, but requires an angiography suite and technical staff. Since hemostasis of retroperitoneal venous bleeding often can be achieved by external pelvic fixation, angioembolization is required for the 11% arterial bleedings which are hard to control by packing. Even though many authors see both methods as complements, time is crucial in the multitrauma setting and the severely injured patient does not tolerate multiple interventions well. Until now good predictors for treatment choice are unavailable, and management of hemodynamically unstable pelvic fractures remains a matter of debate.

This study was designed to answer following questions:
  • Is retroperitoneal pelvic packing or angiography superior with regard to in-hospital mortality, complications, required secondary procedures, or post-intervention blood loss?

  • Which of these methods is the more rapid intervention in the acute setting?

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures - Quasi-randomized Clinical Trial of 56 Hemodynamically Unstable Patients With Injury Severity Score ≥ 33
Study Start Date :
Feb 1, 2003
Actual Primary Completion Date :
Feb 1, 2013
Actual Study Completion Date :
Feb 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: ANGIO

Patients with persistent hemodynamic instability (systolic blood pressure (SBP) <90 mmHg after the transfusion of 4 packed red blood cell (PRBC) units in the emergency department) were taken urgently to the angiography suite for pelvic angiography. These patients had to tolerate transfer to the suite. Patients receiving primarily angioembolization therapy were defined as the ANGIO group.

Procedure: ANGIO
Using en endovascular approach, bleeding arteries are identified and clotted using embolizing agents, or coils.
Other Names:
  • angioembolization
  • Active Comparator: PACKING

    Indication for pelvic packing was persistent SBP<90 mmHg during the initial resuscitation period with 3000 ml of intravenous (IV) crystalloids and transfusion of 4 PRBC units. These patients were treated primarly with retroperitoneal packing, while angioembolization OR staff was unavailable (5pm-7am), and were defined as the PACK group.

    Procedure: PACKING
    By retroperitoneal access the space in front of the pelvic fracture is compressed with surgical towels, which stops effectively venous bleeding
    Other Names:
  • retroperitoneal pelvic packing
  • Outcome Measures

    Primary Outcome Measures

    1. Number of participants deceased occurring in-hospital during or after treatment with packing or embolization [participants will be followed for the duration of hospital stay, an expected average of 6 weeks]

    Secondary Outcome Measures

    1. Number of Participants with Adverse Events as a Measure of Safety and Tolerability [participants will be followed for the duration of hospital stay, an expected average of 6 weeks]

    2. Number of postoperative packed red blood cell units administered for each participant [participants will be followed for the duration of hospital stay, an expected average of 6 weeks]

    3. Number of participants which required a secondary procedure (PACKING or ANGIO) after the primary intervention (PACKING or ANGIO) [participants will be followed for the duration of hospital stay, an expected average of 6 weeks]

      Packing for ANGIO and angioembolization for PACKING.

    4. Time from admission (in minutes) to treatment (PACKING or ANGIO) for each participant [participants will be followed for the duration of hospital stay, an expected average of 6 weeks]

    5. Procedural/surgical time (in minutes) for each participant [participants will be followed for the duration of hospital stay, an expected average of 6 weeks]

    6. Days on ICU for each participant [participants will be followed for the duration of hospital stay, an expected average of 6 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • multitrauma defined as Injury Severity Score (ISS) > 17

    • dislocated pelvic fracture type B or C according to Tile[10] on emergency department pelvic radiograph

    • hemodynamic instability defined as systolic blood pressure (SBP) <90 mmHg after administration of 4 units of packed red blood cells (PRBC).

    Exclusion Criteria:
    • monotrauma, or ISS ≤ 17

    • age > 65 years

    • age < 18 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shandong Provincial Hospital Jinan Shandong China 250021

    Sponsors and Collaborators

    • Uppsala University
    • Shandong Provincial Hospital

    Investigators

    • Study Director: Dongsheng Zhou, MD, PhD, Shandong Provincial Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Uppsala University
    ClinicalTrials.gov Identifier:
    NCT02535624
    Other Study ID Numbers:
    • PELVIC001
    First Posted:
    Aug 28, 2015
    Last Update Posted:
    Oct 30, 2017
    Last Verified:
    Oct 1, 2017

    Study Results

    No Results Posted as of Oct 30, 2017